The Precision Medicine World Conference (PMWC) formerly known as the Personalized Medicine World Conference is the only fully integrated conference to examine the advances and challenges of Personalized Medicine through a practical lens. PMWC brings together the thought-leaders of business, government, healthcare-delivery, research and technology into one information-rich, three-day conference.
Co-hosts: Stanford Health Care, UCSF, Intermountain Health, Duke University and Duke Health.
The conference format consists of two main tracks (1 and 2) and two parallel tracks (3 and 4). Tracks 1 and 2 include sessions by leaders in the commercial, pharmaceutical, academic, government, regulatory, venture capital, and non-profit arenas that deliver a broad and up-to-date array of content across the various facets of precision medicine. Session discussions focus on time-relevant aspects with a selected set of key stakeholders, while commercial sessions cover the latest developments in technologies that are instrumental for the success of further adoption of precision medicine.
In parallel Tracks 3 and 4, the “Most Promising Company Competition” segment identifies “rising stars” startup companies in the area of diagnostics, therapeutics, and health tech via a platform that includes leading investors. Additionally, companies and research institutions can promote their platforms, launch products, and share research developments to a targeted audience.